ERCC1/ERCC4 5-endonuclease activity as a determinant of hypoxic cell radiosensitivity

Author： Murray D.   Macann A.   Hanson J.   Rosenberg E.  

Publisher： Informa Healthcare

ISSN： 1362-3095

Source： International Journal of Radiation Biology, Vol.69, Iss.3, 1996-03, pp. : 319-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of ERCC5 polymorphism in risk of hepatocellular carcinoma

By        

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 911-914

Spandidos Publications

Access to resources Recommend Favorite

FLEX data, KRAS and ERCC1 testing in oncology

By Stebbing Justin  

Future Oncology, Vol. 4, Iss. 4, 2008-08 ,pp. : 471-473

Future Medicine

Access to resources Recommend Favorite

Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients

By Park So-Yeon   Hong Yun-Chul   Kim Jin-Hee   Kwak Seung-Min   Cho Jae-Hwa   Lee Hong-Lyeol   Ryu Jeong-Seon  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 489-498

Humana Press, Inc

Access to resources Recommend Favorite

ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines

By              

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2423-2428

Spandidos Publications

Access to resources Recommend Favorite

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells

By Cheng Haiying  

Carcinogenesis, Vol. 34, Iss. 4, 2013-04 ,pp. : 739-749

Oxford University Press

Access to resources Recommend Favorite